Regulation of atrial contraction by PKA and PKC during development and regression of eccentric cardiac hypertrophy

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 288, Issue 2 57-2, 2005, Pages

  Haddad, Georges E ^a   Coleman, Bernell R ^a   Zhao, Aiqiu ^a   Blackwell, Krista N ^a  

^a HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Angiotensin converting enzyme; Atrium; Contraction; Muscle

Indexed keywords

3 [8 [(DIMETHYLAMINO)METHYL] 6,7,8,9 TETRAHYDROPYRIDO[1,2 A]INDOL 10 YL] 4 (1 METHYL 1H INDOL 3 YL) 1H PYRROLE 2,5 DIONE; ANGIOTENSIN; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; KT 5720;

ANIMAL TISSUE; AORTOCAVAL FISTULA; ARTICLE; CONTROLLED STUDY; ELECTROSTIMULATION; HEART ATRIUM CONTRACTION; HEART VENTRICLE HYPERTROPHY; INOTROPISM; MALE; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOOD PRESSURE; CAPTOPRIL; CARDIOMEGALY; CYCLIC AMP-DEPENDENT PROTEIN KINASES; HEART; HEART ATRIA; MALE; MYOCARDIAL CONTRACTION; MYOCARDIUM; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY;

EID: 12344320001     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00783.2004     Document Type: Article

References (45)

1. Amiri F and Garcia R. Renal angiotensin II receptors and protein kinase C in diabetic rats: effects of insulin ACE inhibition. Am J Physiol Renal Physiol 278: F603-F612, 2000.
2. Baudet S, Weisser J, Janssen AP, Beulich K, Bieligk TJ, Pieske B, Noireaud J, Janssen PM, Hasenfuss G, and Prestle J. Increased basal contractility of cardiomyocytes overexpressing protein kinase C-ε and blunted positive inotropic response to endothelin-1. Cardiovasc Res 50: 486-491, 2001.
3. Bauer P, Regitz-Zagrosek V, Kallisch H, Linz W, Schoelkens B, Hildebrandt AG, and Fleck E. Myocardial angiotensin receptor type I gene expression in a rat model of cardiac volume overload. Basic Res Cardiol 92: 139-146, 1997.
4. Braun MU, Szalai P, Strasser RH, and Borst MM. Right ventricular hypertrophy and apoptosis after pulmonary artery banding: regulation of PKC isozymes. Cardiovasc Res 59: 658-667, 2003.
5. Braz JC, Gregory K, Pathak A, Zhao W, Sahin B, Klevitsky R, Kimball TF, Lorenz JN, Nairn AC, Liggett SB, Bodi I, Wang S, Schwartz A, Lakatta EG, Depaoli-Roach AA, Bobbins J, Hewett TR, Bibb JA, Westfall MV, Kranias EG, and Molkentin JD. PKC-α regulates cardiac contractility and prospensity toward heart failure. Nat Med 10: 248-254, 2004.
6. Chen L, Hahn H, Wu G, Chen CH, Liron T, Schechtman D, Cavallaro G, Band L, Guo Y, Bolli R, Dorn GW II, and Mochly-Rosen D. Opposing cardioprotective actions and parallel hypertrophic effects of δ PKC and ε PKC. Proc Natl Acad Sci USA 98: 11114-11119, 2001.
7. D'Amico C, Paterna S, Di Pasquale P, Antona A, Palazzoadriano M, and Licata G. Effect of captopril on lymphocytic β-adrenergic receptors in normal and hypoxic conditions. Int J Cardiol 44: 137-143, 1994.
8. Dell'italia LJ, Balcells E, Meng QC, Su X, Schultz D, Bishop SP, Machida N, Straeter-Knowlen IM, Hankes GH, Dillon R, Cartee RE, and Oparil S. Volume-overload cardiac hypertrophy is unaffected by ACE inhibitor treatment in dogs. Am J Physiol Heart Circ Physiol 273: H961-H970, 1997.
9. De Mello W and Altieri P. Enalapril, an inhibitor of angiotensin- converting enzyme, increases the junctional conductance in isolated heart cell pairs. J Cardiovasc Pharmacol 18: 643-646, 1991.
10. De Mello W and Altieri P. The role of the renin-angiotensin system in the control of cell communication in the heart: effects of enalapril and angiotensin II. J Cardiovasc Pharmacol 20: 643-651, 1992.
11. 2+ modulation. Circ Res 78: 302-311, 1996.
12. Garcia R and Diebold S. Simple, rapid, and effective method of producing aortocaval shunts in the rat. Cardiovasc Res 24: 430-432, 1990.
13. Goutsouliak V and Rabkin SW. Angiotensin II-induced inositol phosphate generation is mediated through tyrosine kinase pathways in cardiomyocytes. Cell Signal 9: 505-512, 1997.
14. Haddad G and Garcia R. Effect of angiotensin converting enzyme two-week inhibition on renal ANG II receptors, and reactivity of renal vessels of the SHR. J Mol Cell Cardiol 29: 813-822, 1997.
15. Haddad G, Saadeh F, Sharaf L, Nahle Z, Abou-Fares M, Haddad R, Bitar K, and Bikhazi A. Alterations in IGF-I binding on cardiac myofibers and capillary endothelium during chronic volume-overload-induced hypertrophy. J Biochem Mol Biol Biophys 3: 65-74, 1999.
16. Haddad G, Sperelakis N, and Bkaily G. Regulation of the calcium slow channel by cyclic GMP-dependent protein kinase in chick heart cells. Mol Cell Biochem 148: 89-94, 1995.
17. 1 antagonist. Can J Physiol Pharmacol 81: 142-149, 2003.
18. Harrap SB, Van der Merwe WM, Griffin SA, MacPherson F, and Lever AF. Brief angiotensin-converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long-term. Hypertension 16: 603-614, 1990.
19. Holmer SR, Bruckschlegel G, Schunkert H, Rataj DB, Kromer EP, and Riegger GA. Functional activity and expression of the myocardial postreceptor adenylyl cyclase system in pressure overload hypertrophy in rat. Cardiovasc Res 31: 719-728, 1996.
20. Ishiye M, Umemura K, Uematsu T, and Nakashima M. Effects of Iosartan, an angiotensin II antagonist, on the development of cardiac hypertrophy due to volume overload. Biol Pharm Bull 18: 700-704, 1995.
21. Iwai N, Shimoike H, and Kinoshita M. Cardiac renin-angiotensin system in the hypertrophied heart. Circulation 92: 2690-2696, 1995.
22. Kanayama Y, Negoro N, Okamura M, Konishi Y, Nishimura M, Umetani N, Inoue T, and Takeda T. Modulation of protein kinase C in aorta of spontaneously hypertensive rats with enalapril treatment. Osaka City Med J 40: 83-97, 1995.
23. Kim S, Sada T, Mizumo M, Ikeda M, Yano M, Miura K, Yamanaka S, Koike H, and Iwao H. Effects of angiotensin AT, receptor antagonist on volume overload-induced cardiac gene expression in rats. Hypertens Res 20: 133-142, 1997.
24. Lavandero S, Cartagena G, Guarda E, Corbalan R, Godoy I, Sapag-Hagar M, and Jalil JE. Changes in cyclic AMP-dependent protein kinase and active stiffness in the rat volume overload model of heart hypertrophy. Cardiovasc Res 27: 1634-1638, 1993.
25. Lear W, Ruzicka M, and Leenen FH. ACE inhibitors and cardiac ACE mRNA in volume overload-induced cardiac hypertrophy. Am J Physiol Heart Circ Physiol 273: H641-H646, 1997.
26. McCall E, Kenneth GS, Bassani RA, Shannon TR, Qi M, Samarel A, and Bers DM. Ca flux, contractility, and excitation-contraction coupling in hypertrophic rat ventricular myocytes. Am J Physiol Heart Circ Physiol 274: H1348-H1360, 1998.
27. Mukherjee R and Spinale FG. L-type calcium channel abundance and function with cardiac hypertrophy and failure: a review. J Mol Cell Cardiol 30: 1899-1916, 1998.
28. s cross-talk regulates collagen production in cardiac fibroblasts. J Biol Chem 278: 24461-24468, 2003.
29. Pechanova O and Bernatova I. Effect of captopril on cyclic nucleotide concentrations during long-term NO synthase inhibition. Physiol Res 49: 55-63, 2000.
30. Pi Y, Sreekumar R, Huang X, and Walker JW. Positive inotropy mediated by diacylglycerol in rat ventricular myocytes. Circ Res 81: 92-100, 1997.
31. 2+ sensitivity and ATPase activity in the mouse myocardium. J Physiol 552: 845-857, 2003.
32. Schaub MC, Hefti MA, Zuellig RA, and Morano I. Modulation of contractility in human cardiac hypertrophy by myosin essential light chain isoforms. Cardiovasc Res 37: 381-404, 1998.
33. Sheehan KA and Blatter LA. Regulation of junctional and non-junctional sarcoplasmic reticulum calcium release in excitation-contraction coupling in cat atrial myocytes. J Physiol 546: 119-135, 2003.
34. 1 receptor antagonist on cardiac hypertrophy. Mol Cell Biochem 248: 197-202, 2003.
35. Sperelakis N, Xiong Z, Haddad G, and Masuda H. Regulation of slow calcium channels of myocardial cells and vascular smooth muscle cells by cyclic nucleotides and phosphorylation. Mol Cell Biochem 140: 103-117, 1994.
36. Takeishi Y, Bhagwat A, Ball NA, Kirkpatrick DL, Periasamy M, and Walsh RA. Effect of angiotensin-converting enzyme inhibition on protein kinase C and SR proteins in heart failure. Am J Physiol Heart Circ Physiol 276: H53-H62, 1999.
37. Timmermans PB, Duncia JV, Carini DJ, Chiu AT, Wong PC, Wexler RR, and Smith RD. Discovery of losartan, the first angiotensin II receptor antagonist. J Hum Hypertens 9: S3-S18, 1995.
38. Tojo T, Tsunada Y, Nakada S, and Tomoika H. Effects of long-term treatment with non-selective endothelin antagonist, TAK-04, on remodeling of cardiovasculature with sustained volume overload. J Cardiovasc Pharmacol 35: 777-785, 2000.
39. Touyz RM and Berry C. Recent advances in angiotensin II signaling. Braz J Med Biol Res 35: 1001-1015, 2002.
40. Unger T. The role of the renin-angiotensin system in the development of cardiovascular disease. Am J Cardiol 89: 3A-10A, 2002.
41. Venema RC and Kuo JF. Protein kinase C-mediated phosphorylation of troponin I and C-protein in isolated myocardial cells is associated with inhibition of myofibrillar actomyosin Mg-ATPase. J Biol Chem 268: 2705-2711, 1993.
42. Vulpis V, Lograno MD, Seccia TM, and Pirrelli A. L-type calcium channels modulate the regression of left ventricular hypertrophy after ACE inhibition in genetic hypertension. Pharmacol Res 38: 317-322, 1998.
43. Westfall MV and Borton AR. Role of troponin I phosphorylation in protein kinase C-mediated enhanced contractile performance of rat myocytes. J Biol Chem 278: 33694-33700, 2003.
44. qα. J Biol Chem 275: 29927-29930, 2000.
45. Yonemochi H, Yasunaga S, Teshima Y, Iwao T, Akiyoshi K, Nakagawa M, Saikawa T, and Ito M. Mechanism of β-adrenergic receptor upregulation induced by ACE inhibition in cultured neonatal rat cardiac myocytes: roles of bradykinin and protein kinase C. Circulation 97: 2268-2273, 1998.